There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 3 | 73 | 1705 |
| 1 | 1 | 1704 |
| 1 | 1 | 1703 |
| 1 | 1 | 1702 |
| 4 | 62 | 1701 |
| Ask | Qty | Orders |
|---|---|---|
| 1708.6 | 1 | 10 |
| 1712 | 1 | 5 |
| 1712.4 | 1 | 10 |
| 1715 | 1 | 2 |
| 1717.5 | 1 | 10 |
Annual Revenue,rose 13.44%, in the last year to ₹1,995.34 Cr. Its sector's average revenue growth for the last fiscal year was 20.05%.Price to Earning Ratio,is 55.31, lower than its sector PE ratio of 58.25.Quarterly Revenue,rose 30.3% YoY to ₹558.78 Cr. Its sector's average revenue growth YoY for the quarter was 27.08%.
Poly Medicure Ltd. (Polymed) is a leading Indian manufacturer and exporter of medical devices, established in 1995. The company offers a diverse portfolio of 200+ products spanning infusion therapy, anaesthesia, oncology, urology, and gastroenterology, and exports to more than 125 countries, supported by state-of-the-art manufacturing facilities that adhere to international quality standards and certifications. Polymed manufactures and supplies devices across infusion therapy, oncology, anaesthesia and respiratory care, urology, gastroenterology, vascular access, surgery and wound drainage, dialysis and renal care, diagnostics, transfusion systems, veterinary medical devices and others.
The company states it is the largest exporter of medical devices from India, with 70% of sales from exports to highly regulated developed markets like the EU, LATAM and South-East Asia; it is also among the top three IV cannula manufacturers globally and the first indigenous dialyzer manufacturer. Polymed’s footprint includes multiple units in Faridabad (Haryana), Haridwar (Uttarakhand) and Jaipur (SEZ, Rajasthan), along with overseas sites in Amaro, Italy; Laiyang–Qingdao, China; and Assuit, Egypt; the R&D Centre is located in Faridabad. As on the latest year, the company had 3 subsidiaries (and 3 step-subsidiaries) and employed 3,082 people.
These designations are as presented in the Annual Report’s statutory sections and financial statement sign-offs.
As of 22 Aug 2026, the share price of Poly Medicure Ltd is ₹1,718.00 on the NSE and ₹1,712.00 on the BSE. The stock opened at ₹1,775.00, touched a high of ₹1,783.80 and a low of ₹1,710.00 during today's session.
The intraday low for Poly Medicure Ltd on the NSE today was ₹1,710.00. The stock's 52-week low stands at ₹1,182.00, recorded on 30 Mar 2026. Today's low is 44.67% above the 52-week low, indicating the stock is trading well above its yearly lows.
The intraday high for Poly Medicure Ltd on the NSE today (22 Aug 2026) was ₹1,783.80. This compares to the 52-week high of ₹2,144.90 recorded on 04 Sep 2025. Today's high was -16.84% below the 52-week high.
Yes,Poly Medicure Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 15.50 per share between FY2022 and FY2026, with the most recent dividend of ₹3.50 per share for May 26, with an ex-dividend date of 28 Aug 2026. At the current market price of ₹1,718.00, the trailing dividend yield of Poly Medicure Ltd stands at 6.50%.
Poly Medicure Ltd has delivered -14.54% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,144.90 on 04 Sep 2025 and a 52-week low of ₹1,182.00 on 30 Mar 2026. It is currently trading at ₹1,718.00 as of 22 Aug 2026.
Poly Medicure Ltd has delivered a 91.41% absolute return over the past 5 years, equivalent to a CAGR of 13.87% per annum. The stock was priced at ₹897.55 in Aug 2021 and has risen to ₹1,718.00 as of 22 Aug 2026. An investment of ₹1,00,000 in Poly Medicure Ltd five years ago would be worth ₹1,91,410.00 today.
The all-time high (ATH) for Poly Medicure Ltd was ₹3,128.90, recorded on 01 Nov 2024. At the current price of ₹1,718.00, the stock is trading 45.09% below its all-time high. The all-time low recorded was ₹24.83 on 28 Dec 2011.
Poly Medicure Ltd has delivered a return of 10.72% over the last 3 months. The stock was trading at ₹1,598.20 on 22 May 2026 and is currently at ₹1,718.00 as of 22 Aug 2026, reflecting a Gain of ₹119.80 per share over this period.
For Q1 FY27, Poly Medicure Ltd reported: Revenue (Net Sales): ₹4310.99 Cr - Down -2.69% year-on-year from ₹4430.15 Cr in Q4 FY26. Net Income (PAT): ₹881.24 Cr - Up 9.31% year-on-year from ₹806.22 Cr in Q4 FY26.
Over the last 6 months, Poly Medicure Ltd has given a return of 39.47%. The stock was priced at ₹1,268.80 on 23 Feb 2026 and has Rise to ₹1,718.00 as of 22 Aug 2026, a change of ₹449.20 per share.
